We noted with concern the departure of specialized engineering companies in the pharmaceutical market and the creation of a large gap in the segment. Many of the professionals in the business have changed their activity or left the country in search of opportunities.
In 2019 we are closely monitoring the pharmaceutical regulatory framework and the harmonization of Brazilian standards with international standards through participation in PIC/S and ICH. This normative change will certainly come accompanied by the need for business adequacy and consequent demand for specialized consulting services.
In short, the pharmaceutical engineering market in Brazil is increasingly dynamic and companies working in this segment need to adapt in the same way. That is why Nordika do Brasil has decided to invest part of its best resources in the creation of a consulting division specialized in solutions for the pharmaceutical industry – welcome to Nordika Consulting.
The main objective of Nordika Consulting is to offer services of high added value, developed by highly qualified professionals. We are prepared to offer the following specialized activities:
- Feasibility Studies and Conceptual Projects;
- GMP Assessment;
- Gap Analysis of engineering projects;
- Due Dilligence in pharmaceutical plants;
- Representation of the client in management contracts – Owners Representative;
- Internal Audits directed to specific topics;
- Audits in Third Parties;
- Risk Analysis;
- Training through the Nordika Academy program.